← Leaderboards
Harvey Klein
Clinical Center
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Center
Same institution · by research overlap
Others in their field
Top investigators on “B-Lymphocytes”
- Barton F Haynes · Duke University$400,419,833
- Lawrence Corey · Fred Hutchinson Cancer Center$83,920,398
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$83,920,398
- Dan H. Barouch · Fred Hutchinson Cancer Center$66,039,430
- Dennis R. Burton · Scripps Research Institute$63,566,673
- Rafi Ahmed · Emory University$62,743,001
Research focus
B-LymphocytesMicrornasLeukocytesT-LymphocyteGene TherapyMonocyteCell PhysiologyHematopoietic Stem CellsPeripheral BloodProductionUnmarried PersonEnzyme Linked Immunospot AssayGenesGene Expression ProfilingEnzyme-Linked Immunosorbent AssayClinical EffectivenessComplexCellsSterility TestingGenetic TranscriptionCell TherapyCell Culture TechniquesLaboratoriesDendritic Cells
Grant awards (10)
Viral And Immune Factors That Influence Recovery Or Progression Of Hepatitis C$0
ZIA · FY2019 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
ZIA · FY2019 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
ZIA · FY2018 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
ZIA · FY2017 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
ZIA · FY2016 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
ZIA · FY2015 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
ZIA · FY2014 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
ZIA · FY2012 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
ZIA · FY2010 · CL · contact PI
Develop novel assays for assessing cellular and gene therapies$0
Z01 · FY2008 · CL · contact PI